טוען...

Outcomes Following Neoadjuvant or Adjuvant Chemotherapy for cT2-4N0-1 Non-Small Cell Lung Cancer: A Propensity-Matched Analysis

OBJECTIVE: Comparative survival between neoadjuvant chemotherapy (NC) and adjuvant chemotherapy (AC) for patients with cT2-4N0-1M0 non-small cell lung cancer (NSCLC) has not been extensively studied. METHODS: Patients with cT2-4N0-1M0 NSCLC who received platinum-based chemotherapy were retrospective...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Thorac Cardiovasc Surg
Main Authors: Brandt, Whitney S., Yan, Wanpu, Zhou, Jian, Tan, Kay See, Montecalvo, Joseph, Park, Bernard J., Adusumilli, Prasad S., Huang, James, Bott, Matthew J., Rusch, Valerie W., Molena, Daniela, Travis, William D., Kris, Mark G., Chaft, Jamie E., Jones, David R.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344258/
https://ncbi.nlm.nih.gov/pubmed/30415902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.09.098
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!